Search

Author/Creator Dobreanu, Dan

1. Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial. (27th August 2022)

Authors:
Ostrominski, John W.; Vaduganathan, Muthiah; Claggett, Brian L.; de Boer, Rudolf A.; Desai, Akshay S.; Dobreanu, Dan; Hernandez, Adrian F.; Inzucchi, Silvio E.; Jhund, Pardeep S.; Kosiborod, Mikhail; Lam, Carolyn S.P.; Langkilde, Anna M.; Lindholm, Daniel; Martinez, Felipe A.; O'Meara, Eileen; Pe...
Journal:
European journal of heart failure
Issue:
Volume 24:Number 10(2022)
Page Start:
1892
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial. Issue 14 (6th March 2023)

Authors:
Kondo, Toru; Jering, Karola S.; Borleffs, C. Jan Willem; de Boer, Rudolf A.; Claggett, Brian L.; Desai, Akshay S.; Dobreanu, Dan; Inzucchi, Silvio E.; Hernandez, Adrian F.; Janssens, Stefan P.; Jhund, Pardeep S.; Kosiborod, Mikhail N.; Lam, Carolyn S.P.; Langkilde, Anna Maria; Martinez, Felipe A....
Journal:
Circulation
Issue:
Volume 147:Issue 14(2023)
Page Start:
1067
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Patients' knowledge and attitudes regarding living with implantable electronic devices: results of a multicentre, multinational patient survey conducted by the European Heart Rhythm Association. Issue 2 (28th December 2017)

Authors:
Haugaa, Kristina Hermann; Potpara, Tatjana S; Boveda, Serge; Deharo, Jean-Calude; Chen, Jian; Dobreanu, Dan; Fumagalli, Stefano; Lenarczyk, Radoslaw; Hernandez Madrid, Antonio; Larsen, Torben Bjerregaard; Sciarrafia, Elena; Taborsky, Milos; Tilz, Roland Richard; Pieragnoli, Paolo; Przybylski, And...
Journal:
Europace
Issue:
Volume 20:Issue 2(2018)
Page Start:
386
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Plasma lipids affect dabigatran etexilate anticoagulation in rats with unbalanced diabetes mellitus: 在失衡的糖尿病大鼠中血脂可以影响达比加群酯的抗凝作用. Issue 3 (13th September 2017)

Authors:
Scridon, Alina; Perian, Marcel; MĂrginean, Alina; Huţanu, Adina; Gherţescu, Doina; Vântu, Adriana; FişcĂ, Paul C.; Chevalier, Philippe; Şerban, Răzvan C.; Dobreanu, Dan
Journal:
Journal of diabetes
Issue:
Volume 10:Issue 3(2018)
Page Start:
240
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Vascular protease‐activated receptor 4 upregulation, increased platelet aggregation, and coronary lipid deposits induced by long‐term dabigatran administration – results from a diabetes animal model. (6th February 2019)

Authors:
Scridon, Alina; Mărginean, Alina; Huțanu, Adina; Chinezu, Laura; Gheban, Dan; Perian, Marcel; Vântu, Adriana; Gherțescu, Doina; Fișcă, Paul C.; Șerban, Rǎzvan C.; Chevalier, Philippe; Dobreanu, Dan
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 17:Number 3(2019)
Page Start:
538
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗